Neue Suche | Kongressdetail
Druckansicht
 
 

Striving towards the elimination of HCV infection, Berlin 2018

EASL The Home of Hepatology
Kongressthemen
Globally, morbidity and mortality due to HCV infection continues to rise. However, the availability of simple and tolerable DAA therapies for HCV infection with cure rates >90% is one of the greatest medical advances in decades. This has brought considerable optimism to people working in HCV. The WHO has set an ambitious goal to eliminate HCV as a major public health threat by 2030.
Kongressorganizer (PCO)
evvnt Platform / evvnt
Anmerkungen
Url:

Booking: https://go.evvnt.com/147888-1

Speakers: Prof. Francesco Negro, Dr. Alessio Aghemo, Prof. Jason Grebely
 

Anfragen und Anmeldung:

Herr EASL The Home of Hepatology
 
Kategorien
Allgemeinmedizin
Sprache
Englisch
Kongressgebühr
EASL Member Early fee: EUR 300 EASL Member: EUR 450 Non Member Early fee: EUR 450 Non Member : EUR 550
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
Tel: +44 0207 3230 450
hello@evvnt.com
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation European Health Forum GasteinÖsterreichische Akademie der ÄrzteAnästhesie in Entwicklungsländern e. V.AMREF - African Medical and Research FoundationSwiss Tropical and Public Health InstitutenewTreeÖsterreichische Gesellschaft für Public Health

Facebook

Sagen Sie uns Ihre professionelle Meinung

Zur Umfrage

Zur Umfrage